Get started
Author

Sally E. Trabucco

Observed names: S.E. Trabucco, Sally E Trabucco, Sally Trabucco, Sally E. Trabucco, Trabucco, Sally E.
ORCID: 0000-0002-8836-1542
Observed ORCID: 0000-0002-8836-1542
OpenAlex ID: A5009917980
STK11/LKB1 Mutations and PD-1 Inhibitor Resistance in KRAS -Mutant Lung Adenocarcinoma
2018 · Ferdinandos Skoulidis, Michael E. Goldberg, et al. · Cancer Discovery · 1,727
A Novel Next-Generation Sequencing Approach to Detecting Microsatellite Instability and Pan-Tumor Characterization of 1000 Microsatellite Instability–High Cases in 67,000 Patient Samples
2019 · Sally E. Trabucco, Kyle Gowen, et al. · Journal of Molecular Diagnostics · 236
PDF
Clinical genomic profiling in the management of patients with soft tissue and bone sarcoma
2022 · Mrinal M. Gounder, Narasimhan P. Agaram, et al. · Nature Communications · 226
PDF
Functional characterization of SMARCA4 variants identified by targeted exome-sequencing of 131,668 cancer patients
2020 · Tharu M. Fernando, Robert Piskol, et al. · Nature Communications · 174
PDF
Actionable Activating Oncogenic ERBB2/HER2 Transmembrane and Juxtamembrane Domain Mutations
2018 · Kanika Bajaj Pahuja, Thong T. Nguyen, et al. · Cancer Cell · 168
PDF
Inhibition of Bromodomain Proteins for the Treatment of Human Diffuse Large B-cell Lymphoma
2014 · Sally E. Trabucco, Rachel M. Gerstein, et al. · Clinical Cancer Research · 149
Oxidative Stress, Mitochondrial Dysfunction and the Mitochondria Theory of Aging
2014 · Yahui Kong, Sally E. Trabucco, et al. · Interdisciplinary topics in gerontology and geriatrics · 121
Recurrent hyperactive ESR1 fusion proteins in endocrine therapy-resistant breast cancer
2018 · R.J. Hartmaier, S.E. Trabucco, et al. · Annals of Oncology · 111
PDF
A clinico-genomic analysis of soft tissue sarcoma patients reveals CDKN2A deletion as a biomarker for poor prognosis
2019 · Nam Q. Bui, Joanna Przybyl, et al. · Clinical Sarcoma Research · 88
PDF
The genomic landscape of metastatic breast cancer: Insights from 11,000 tumors
2020 · Jacob Rinaldi, Ethan S. Sokol, et al. · PLoS ONE · 60
PDF
PARP Inhibitor Insensitivity to BRCA1/2 Monoallelic Mutations in Microsatellite Instability-High Cancers
2022 · Ethan S. Sokol, Dexter X. Jin, et al. · JCO Precision Oncology · 50
PDF
BRAF in Lung Cancers: Analysis of Patient Cases Reveals Recurrent BRAF Mutations, Fusions, Kinase Duplications, and Concurrent Alterations
2018 · Yuri Sheikine, Dean Pavlick, et al. · JCO Precision Oncology · 50
Integrated DNA/RNA targeted genomic profiling of diffuse large B-cell lymphoma using a clinical assay
2018 · Andrew M. Intlekofer, Erel Joffe, et al. · Blood Cancer Journal · 36
PDF
The Pan-Cancer Landscape of Coamplification of the Tyrosine Kinases KIT, KDR, and PDGFRA
2019 · Umut Disel, Russell Madison, et al. · The Oncologist · 29
PDF
Multiple PIK3CA mutation clonality correlates with outcomes in taselisib + fulvestrant-treated ER+/HER2–, PIK3CA-mutated breast cancers
2023 · Katherine E. Hutchinson, Jessica W. Chen, et al. · Genome Medicine · 24
PDF
Genomic profiling of solid tumors harboring BRD4-NUT and response to immune checkpoint inhibitors
2021 · Jonathan W. Riess, Shaila Rahman, et al. · Translational Oncology · 23
YY1 Regulates the Germinal Center Reaction by Inhibiting Apoptosis
2016 · Sally E Trabucco, Rachel M Gerstein, et al. · The Journal of Immunology · 22
Clinicopathologic, genomic and protein expression characterization of 356 ROS1 fusion driven solid tumors cases
2020 · Richard S. P. Huang, James Haberberger, et al. · International Journal of Cancer · 21
PDF
Smurf2 regulates hematopoietic stem cell self‐renewal and aging
2014 · Charusheila Ramkumar, Yahui Kong, et al. · Aging Cell · 17
PDF
Real-World Clinical Performance of a DNA-Based Comprehensive Genomic Profiling Assay for Detecting Targetable Fusions in Nonsquamous NSCLC
2024 · Philip C Mack, Rachel B Keller-Evans, et al. · The Oncologist · 9
Frequency of genomic biomarkers of response to immunotherapy in sarcoma.
2018 · Sally E. Trabucco, Siraj Mahamed Ali, et al. · Journal of Clinical Oncology · 8
NTRK1-3 genomic fusions in non-small cell lung cancer (NSCLC) determined by comprehensive genomic profiling
2019 · S-H I Ou, E.S. Sokol, et al. · Annals of Oncology · 7
Genomic characteristics and predicted ancestry of NTRK1/2/3 and ROS1 fusion-positive tumours from >165,000 pan-solid tumours
2019 · T.R. Wilson, E.S. Sokol, et al. · Annals of Oncology · 6
PDF
Prediction and Characterization of Diffuse Large B-Cell Lymphoma Cell-of-Origin Subtypes Using Targeted Sequencing
2021 · Sally E Trabucco, Ethan S Sokol, et al. · Future Oncology · 5
PDF
Finding Shangri-La: Limiting the Impact of Senescence on Aging
2016 · Sally E. Trabucco, Hong Zhang · Cell stem cell · 5
PDF
Works count: 59
Citation count: 3,381
H-index: 18
I10-index: 19
Year
Topic
Type